406 related articles for article (PubMed ID: 27789360)
1. Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall Survival.
Crombie J; Spring L; Li S; Soiffer RJ; Antin JH; Alyea EP; Glotzbecker B
Biol Blood Marrow Transplant; 2017 Jan; 23(1):113-118. PubMed ID: 27789360
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and survival impact of readmission after single-unit cord blood transplantation for adults.
Yamagishi Y; Konuma T; Miwa Y; Oiwa-Monna M; Tanoue S; Isobe M; Jimbo K; Mizusawa M; Narita H; Kobayashi K; Kato S; Takahashi S; Tojo A
Int J Hematol; 2019 Jan; 109(1):115-124. PubMed ID: 30302739
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).
Bejanyan N; Bolwell BJ; Lazaryan A; Rybicki L; Tench S; Duong H; Andresen S; Sobecks R; Dean R; Pohlman B; Kalaycio M; Copelan EA
Biol Blood Marrow Transplant; 2012 Jun; 18(6):874-80. PubMed ID: 22040844
[TBL] [Abstract][Full Text] [Related]
4. Incidence and causes of hospital readmission in pediatric patients after hematopoietic cell transplantation.
Shulman DS; London WB; Guo D; Duncan CN; Lehmann LE
Biol Blood Marrow Transplant; 2015 May; 21(5):913-9. PubMed ID: 25667988
[TBL] [Abstract][Full Text] [Related]
5. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival.
Spring L; Li S; Soiffer RJ; Antin JH; Alyea EP; Glotzbecker B
Biol Blood Marrow Transplant; 2015 Mar; 21(3):509-16. PubMed ID: 25482866
[TBL] [Abstract][Full Text] [Related]
7. Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults.
Maher OM; Silva JG; Huh WW; Cuglievan B; DePombo A; Kebriaei P; Park M; Liu D; Tillman C; Tarek N; Cooper LJN; Tewari P
J Pediatr Hematol Oncol; 2017 Nov; 39(8):609-613. PubMed ID: 28859043
[TBL] [Abstract][Full Text] [Related]
8. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
[TBL] [Abstract][Full Text] [Related]
9. Readmission to the Intensive Care Unit: Incidence, Risk Factors, Resource Use, and Outcomes. A Retrospective Cohort Study.
Ponzoni CR; Corrêa TD; Filho RR; Serpa Neto A; Assunção MSC; Pardini A; Schettino GPP
Ann Am Thorac Soc; 2017 Aug; 14(8):1312-1319. PubMed ID: 28530118
[TBL] [Abstract][Full Text] [Related]
10. Factors determining post-operative readmissions after left ventricular assist device implantation.
Tsiouris A; Paone G; Nemeh HW; Brewer RJ; Morgan JA
J Heart Lung Transplant; 2014 Oct; 33(10):1041-7. PubMed ID: 25034795
[TBL] [Abstract][Full Text] [Related]
11. Infections of the Central Nervous System after Unrelated Donor Umbilical Cord Blood Transplantation or Human Leukocyte Antigen-Matched Sibling Transplantation.
Balaguer Rosello A; Bataller L; Lorenzo I; Jarque I; Salavert M; González E; Piñana JL; Sevilla T; Montesinos P; Iacoboni G; Muelas N; Romero S; Carretero C; Montoro J; Ibáñez-Juliá MJ; Sanz G; Sanz MÁ; Sanz J
Biol Blood Marrow Transplant; 2017 Jan; 23(1):134-139. PubMed ID: 27794456
[TBL] [Abstract][Full Text] [Related]
12. Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.
Mallhi KK; Smith AR; DeFor TE; Lund TC; Orchard PJ; Miller WP
Biol Blood Marrow Transplant; 2017 Jan; 23(1):119-125. PubMed ID: 27989932
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Rates and Outcomes of Readmission to Index vs Nonindex Hospitals After Major Cancer Surgery.
Zafar SN; Shah AA; Channa H; Raoof M; Wilson L; Wasif N
JAMA Surg; 2018 Aug; 153(8):719-727. PubMed ID: 29641833
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for readmission of orthopaedic surgical patients.
Dailey EA; Cizik A; Kasten J; Chapman JR; Lee MJ
J Bone Joint Surg Am; 2013 Jun; 95(11):1012-9. PubMed ID: 23780539
[TBL] [Abstract][Full Text] [Related]
15. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F
Transplantation; 2013 May; 95(10):1284-91. PubMed ID: 23507699
[TBL] [Abstract][Full Text] [Related]
16. Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis.
Ruggeri A; Volt F; Locatelli F; Michel G; Diaz de Heredia C; Abecasis M; Zecca M; Vora A; Yakouben K; O'Brien TA; Giardino S; Cornish J; Rocha V; Peters C; Bader P; Gluckman E; Dalle JH
Biol Blood Marrow Transplant; 2017 Jan; 23(1):96-102. PubMed ID: 27777140
[TBL] [Abstract][Full Text] [Related]
17. Hospital readmission following transplantation: identifying risk factors and designing preventive measures.
McKenna DR; Sullivan MR; Hill JM; Lowrey CH; Brown JR; Hickman J; Meehan KR
J Community Support Oncol; 2015 Sep; 13(9):316-22. PubMed ID: 26859751
[TBL] [Abstract][Full Text] [Related]
18. Causes and correlates of 30 day and 180 day readmission following discharge from a Medicine for the Elderly Rehabilitation unit.
Hughes LD; Witham MD
BMC Geriatr; 2018 Aug; 18(1):197. PubMed ID: 30153802
[TBL] [Abstract][Full Text] [Related]
19. Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities.
Adachi Y; Ukai S; Sagou K; Fukushima N; Ozeki K; Kohno A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1455-1462. PubMed ID: 29476952
[TBL] [Abstract][Full Text] [Related]
20. Are Readmissions After THA Preventable?
Weinberg DS; Kraay MJ; Fitzgerald SJ; Sidagam V; Wera GD
Clin Orthop Relat Res; 2017 May; 475(5):1414-1423. PubMed ID: 27837400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
